ResearcherSeoul National UniversityNo recent work listed

Kim Js

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5348-9178; OpenAlex author ID A5040505021. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancre… Co-author DOI 10.4143/crt.2020.928 ↗
Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for… Co-author DOI 10.1007/s00280-012-1918-7 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sung Whan Ha · 2 shared papers, 2012–2021 · strength 0.15
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928 ↗
- Paper Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent… DOI 10.1007/s00280-012-1918-7 ↗
Seock‐Ah Im · 2 shared papers, 2012–2021 · strength 0.15
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928 ↗
- Paper Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent… DOI 10.1007/s00280-012-1918-7 ↗
Eui Kyu Chie · 2 shared papers, 2012–2021 · strength 0.15
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928 ↗
- Paper Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent… DOI 10.1007/s00280-012-1918-7 ↗
Yung‐Jue Bang · 2 shared papers, 2012–2021 · strength 0.15
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928 ↗
- Paper Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent… DOI 10.1007/s00280-012-1918-7 ↗
Kyung-Hun Lee · 1 shared paper, 2021 · strength 0.12
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928 ↗
Do‐Youn Oh · 1 shared paper, 2021 · strength 0.12
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928 ↗
Jin‐Young Jang · 1 shared paper, 2021 · strength 0.12
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928 ↗
Sun‐Whe Kim · 1 shared paper, 2021 · strength 0.12
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928 ↗
Jin‐Hyeok Hwang · 1 shared paper, 2012 · strength 0.03
- Paper Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent… DOI 10.1007/s00280-012-1918-7 ↗
Yong Bum Yoon · 1 shared paper, 2012 · strength 0.03
- Paper Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent… DOI 10.1007/s00280-012-1918-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.